23 September 2020

Scientific Committee

  • Claus Andersen, Galapagos
  • Luc Bijnens, Janssen, Belgium
  • Bruno Boulanger, Pharmalex, Belgium
  • Luwis Diya, Janssen, Belgium
  • Bernard Francq, GSK , Belgium
  • Helena Geys, Janssen, Belgium
  • Peter Goos, KULeuven  , Belgium
  • Bernadette Govaerts, UCLouvain, Belgium
  • Leo Held, U. Zurich, Switzerland
  • Thomas Jaki, U. Lancaster, UK
  • Sarah Janssen, Janssen, The Netherlands
  • Pierre Lebrun, PharmaLex, Belgium
  • Véronique Onado, Sanofi, France
  • Els Pattyn, Ablynx, a Sanofi company, Belgium
  • Didier Poirault, bioMérieux, France
  • Kit Roes, U. Utrecht, The Netherlands
  • Olivier Thas,  Ghent University, Belgium
  • Hannes-Friedrich Ulbrich, Bayer, Germany
  • David Wille, GSK, UK